The blockbuster model now delivers just 5% return on investment and only one in six new drug prospects will deliver returns above their cost of capital, as a result competitive pressures and falling R ...
IntroductionAlexion Pharmaceuticals (Alexion) is a biotechnology company engaged in the discovery and development of therapeutic products for the treatment of hematological diseases, cancer, and autoi ...
This report examines how pharmaceutical firms can efficiently undertake project management through a variety of methods. It provides three examples of best practice in this area. ...
Datamonitor's Nippon Kayaku Co., Ltd. SWOT company profile is the essential source for top-level company data and information. The report examines the companys key business structure and operat ...
Snapshots International | 12 pages | November 2007 | English
L'étude Snapshots République Tchèque Pharmaceutiques 2007, publiée par Snapshots dans le serie Pharmaceutiques, est disponible uniquement en Anglais pour le moment. Néanmoins, bien que chacun de n ...
The following case study describes how a pharmaceutical licensing deal can initially seem full of potential, but due to a number of reasons, fails to deliver. The experience of Genta and Aventis (n ...
Global Industry Analyst | 244 pages | August 2005 | English
This report analyzes the worldwide markets for Cholesterol & Other Cardiovascular Testing in Millions of Units. The specific product segments analyzed are Lipid Panel Test/Complete Lipid Profile, T ...
Datamonitor | 161 pages | September 2007 | English
IntroductionThis databook is a detailed information resource covering all the key data points on OTC Healthcare in Sweden. It includes comprehensive value volume segmentation and market share data. ...
IntroductionPharmion's main focus is to acquire, develop and commercialize products for the treatment of hematology and oncology patients. As a part of its business strategy, Pharmion intends to ac ...
